Coya Therapeutics (COYA) Other financing activities (2022 - 2025)

Coya Therapeutics (COYA) has 4 years of Other financing activities data on file, last reported at $19137.0 in Q3 2025.

• For the quarter ending Q3 2025, Other financing activities rose 101.27% year-over-year to $19137.0; the trailing twelve-month figure through Dec 2025 stood at $38274.0 (up 1837.92% YoY), and the FY2025 full-year result was $38274.0, up 1837.92% from the prior year.
• Other financing activities steadied at $19137.0 in Q3 2025, from $19137.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $14.3 million in Q1 2023 to a low of -$1.5 million in Q3 2024.
• A 4-year average of $2.0 million and a median of $19137.0 in 2025 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities soared 9019084.18% in 2023 and tumbled 99.99% in 2024, its largest moves.
• Tracing COYA's Other financing activities over 4 years: stood at $158.0 in 2022, then soared by 9019084.18% to $14.3 million in 2023, then slumped by 110.58% to -$1.5 million in 2024, then surged by 101.27% to $19137.0 in 2025.
• Business Quant data shows COYA's Other financing activities at $19137.0 in Q3 2025, $19137.0 in Q1 2025, and -$1.5 million in Q3 2024.